You just read:

Skyhawk Therapeutics Launches With $8 Million in Seed Financing to Advance Its Novel Platform and Portfolio of Small Molecules That Correct RNA Expression

News provided by

Skyhawk Therapeutics, Inc.

Jan 23, 2018, 10:00 ET